Kurt F. Somerville’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.22M Sell
8,934
-2,303
-20% -$2.33M 2.17% 20
2025
Q4
$12.1M Buy
11,237
+2,005
+22% +$1.92M 2.05% 21
2025
Q3
$7.04M Buy
9,232
+1,990
+27% +$1.48M 1.16% 27
2025
Q2
$5.65M Buy
7,242
+3,036
+72% +$2.36M 0.95% 30
2025
Q1
$3.47M Buy
4,206
+494
+13% +$411K 0.6% 36
2024
Q4
$2.87M Sell
3,712
-110
-3% -$91.1K 0.48% 37
2024
Q3
$3.39M Sell
3,822
-128
-3% -$115K 0.55% 36
2024
Q2
$3.58M Sell
3,950
-310
-7% -$248K 0.6% 36
2024
Q1
$3.31M Sell
4,260
-385
-8% -$274K 0.57% 37
2023
Q4
$2.71M Sell
4,645
-196
-4% -$114K 0.51% 37
2023
Q3
$2.6M Sell
4,841
-175
-3% -$90.2K 0.52% 37
2023
Q2
$2.35M Sell
5,016
-165
-3% -$69.2K 0.45% 41
2023
Q1
$1.78M Sell
5,181
-295
-5% -$99.5K 0.32% 47
2022
Q4
$2M Sell
5,476
-50
-0.9% -$17.7K 0.39% 44
2022
Q3
$1.79M Sell
5,526
-5
-0.1% -$1.58K 0.36% 47
2022
Q2
$1.79M Sell
5,531
-164
-3% -$49.2K 0.34% 47
2022
Q1
$1.63M Sell
5,695
-115
-2% -$29.6K 0.26% 50
2021
Q4
$1.6M Buy
5,810
+55
+1% +$13.9K 0.22% 49
2021
Q3
$1.33M Sell
5,755
-305
-5% -$75.3K 0.2% 50
2021
Q2
$1.39M Hold
6,060
0.21% 51
2021
Q1
$1.13M Sell
6,060
-200
-3% -$39.1K 0.18% 53
2020
Q4
$1.06M Hold
6,260
0.17% 55
2020
Q3
$927K Sell
6,260
-175
-3% -$27.1K 0.16% 58
2020
Q2
$1.06M Sell
6,435
-115
-2% -$17.7K 0.19% 57
2020
Q1
$909K Buy
6,550
+1,110
+20% +$153K 0.2% 56
2019
Q4
$715K Sell
5,440
-50
-0.9% -$5.8K 0.13% 60
2019
Q3
$614K Sell
5,490
-25
-0.5% -$2.78K 0.12% 62
2019
Q2
$611K Sell
5,515
-365
-6% -$43K 0.12% 61
2019
Q1
$763K Sell
5,880
-275
-4% -$33.4K 0.15% 59
2018
Q4
$712K Hold
6,155
0.16% 59
2018
Q3
$661K Sell
6,155
-325
-5% -$32.5K 0.13% 65
2018
Q2
$553K Sell
6,480
-100
-2% -$8.21K 0.12% 72
2018
Q1
$509K Sell
6,580
-646
-9% -$52K 0.11% 72
2017
Q4
$610K Sell
7,226
-240
-3% -$20.4K 0.13% 70
2017
Q3
$639K Hold
7,466
0.13% 65
2017
Q2
$614K Hold
7,466
0.13% 68
2017
Q1
$629K Sell
7,466
-100
-1% -$8.01K 0.13% 69
2016
Q4
$557K Hold
7,566
0.12% 76
2016
Q3
$607K Sell
7,566
-66
-0.9% -$5.28K 0.13% 75
2016
Q2
$600K Hold
7,632
0.13% 76
2016
Q1
$550K Hold
7,632
0.13% 76
2015
Q4
$643K Hold
7,632
0.15% 75
2015
Q3
$639K Sell
7,632
-200
-3% -$16.9K 0.16% 73
2015
Q2
$654K Hold
7,832
0.15% 77
2015
Q1
$569K Sell
7,832
-100
-1% -$7.12K 0.13% 78
2014
Q4
$547K Hold
7,932
0.14% 81
2014
Q3
$514K Hold
7,932
0.21% 67
2014
Q2
$493K Sell
7,932
-100
-1% -$5.97K 0.19% 74
2014
Q1
$472K Sell
8,032
-6,000
-43% -$335K 0.19% 76
2013
Q4
$715K Hold
14,032
0.27% 67
2013
Q3
$705K Hold
14,032
0.28% 67
2013
Q2
$690K Buy
+14,032
New +$764K 0.29% 64

Other funds holding LLY

Kurt F. Somerville's LLY Position: Q1 2026 in Review

Kurt F. Somerville reduced its Eli Lilly (LLY) stake by 20% in Q1 2026, selling an estimated $2.33M and leaving 8,934 shares worth $8.22M. The position accounts for 2.17% of the portfolio, ranked #20.

Kurt F. Somerville first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kurt F. Somerville held 8,934 shares of Eli Lilly worth $8.22M as of Q1 2026.
  • Kurt F. Somerville sold 2,303 Eli Lilly shares in Q1 2026, an estimated $2.33M.
  • Eli Lilly made up 2.17% of Kurt F. Somerville's portfolio in Q1 2026, its #20 holding.
  • Kurt F. Somerville first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Kurt F. Somerville's Eli Lilly position peaked at $12.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kurt F. Somerville's 13F filing for Q1 2026, filed 8 May 2026.